15 th ASEICA INTERNATIONAL CONGRESS
|
|
|
- Matthew Porter
- 8 years ago
- Views:
Transcription
1 Sevilla october th ASEICA Spanish Society for Cancer Research Hotel NH Collection Sevilla. Avda Diego Martinez Barrio, 8, Sevilla
2 Organizing Committee President Dr. Pedro Lazo-Zbikowski Dr. Carlos Camps Dr. Noemí Reguart Dr. Gabriel Capellá Dr. Montserrat Sánchez Cespedes Dr. Luis Paz-Ares Dr. Ana Osorio Dr. Arkaitz Carracedo Dr. Jesús Paramio Dr. José Palacios Scientific Committee Dr. Pedro Lazo-Zbikowski Dr. Carlos Camps Dr. Gabriel Capellà Dr. Arkaitz Carracedo Dr. Leonor David Dr. Antonio García de Herreros Dr. Alberto Muñoz Dr. Ana Osorio Dr. José Palacios Dr. Jesús Paramio Dr. Luis Paz-Ares Dr. Héctor Peinado Dr. Noemí Reguart Dr. Montse Sánchez-Céspedes Dr. Joan Seoane Dr. Violeta Serra Dr. George Thomas Dr. Guillermo Velasco Meeting opening Opening conference. ASEICA Lecture Targetting telomeres in cancer Dr. María A. Blasco, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid Sustaining proliferative signaling & evading growth suppressors Chairpersons Dr. Jesús Paramio and Dr. Violeta Serra Linking senescence and inflammation: the senescence-associated secretory phenotype (SASP) Dr. Jesús Gil, MRC Clinical Science Center, Kings College, London, UK Targeting PI3K in breast cancer Dr. Violeta Serra, Hospital Universitari Vall d Hebrón (VHIO), Barcelona Tyrosine kinase inhibitors: from Lazarians responses to the emergence of resistance. A focus in lung cancer Dr. Luis Paz-Ares, Hospital Universitario 12 de Octubre, Madrid
3 Cancer genomics and tumor heterogeneity Chairpersons Dr. Montse Sánchez-Céspedes and Dr. José Palacios Novel gene alterations and biological networks in lung cancer development Dr. Montse Sánchez-Céspedes, Instituto de Investigación Biomédica de Bellvitge (IDIBELL), Barcelona Genomic characterization of the role of intratumor heterogeneity in cancer progression and metastasis Dr. Ignacio Varela, Instituto de Biomedicina y Biotecnología de Cantabria (IBBTEC - UC - CSIC - SODERCAN), Santander Clinical implications of intrinsic breast cancer subtypes Dr. Aleix Prat, Hospital Universitari Clínic, Barcelona Round table: clinical applications of genomics Chairperson Dr. Luis Paz-Ares Clonal evolution and drug resistance: from cancer avatars to liquid biopsies Dr. Alberto Bardelli, University of Torino, Italy Discussants: Dr. Alberto Bardelli, University of Torino, Italy Dr. Joan Albanell, Hospital del Mar-Parc de Salut Mar, Barcelona Dr. Alfonso Berrocal, Hospital General Universitario, Valencia Metabolism. Deregulating cellular energetics Chairpersons Dr. George Thomas and Dr. Arkaitz Carracedo Ribosome biogenesis mediates a novel intrinsic p53 checkpoint in cancer progression Dr. George Thomas, Instituto de Investigación Biomédica de Bellvitge (IDIBELL), Barcelona mtor in intestinal cancer and metabolism Dr. Nabil Djouder, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid Metabolic alterations as biomarkers of efficacy in anticancer therapies targeting the PI3K/AKT/mTOR pathway Dr. Jordi Rodón, Hospital Universitari Vall d Hebrón (VHIO), Barcelona Metabolic reprogramming as an escape mechanism against treatment with multi-tyrosine kinase inhibitors Dr. Miguel Quintela, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid
4 Resisting cell death Chairpersons Dr. Guillermo Velasco and Dr. Gabriel Capellà Signaling mechanisms involved in the regulation of autophagy-mediated cancer cell death Dr. Guillermo Velasco, Universidad Complutense de Madrid, Instituto de Investigaciones Santarias San Carlos, Madrid The two faces of mesenchymal stem cells in myeloid neoplasias Dr. Simón Méndez-Ferrer, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid Cell death induced by inhibition of glucose metabolism Dr. Cristina Muñoz-Pinedo, Instituto de Investigación Biomédica de Bellvitge (IDIBELL), Barcelona Activating invasion & metastasis Chairpersons Dr. Antonio García de Herreros and Dr. Noemí Reguart Snail1, epithelial to mesenchymal transition and fibroblast activation Dr. Antonio García de Herreros, Universidad Pompeu Fabra (UPF), Barcelona Microenviromental regulation of disseminated tumour cells dormancy Dr. Paloma Bragado, Institut d Investigacions Biomèdiques Agustí Pi i Sunyer (IDIBAPS), Barcelona Signalling networks in inflammation and cancer Dr. Erwin Wagner, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid SATELLITE SYMPOSIUM Lunch Poster session with presenters (odd numbers from to 15.00h, even numbers from to 16.00h)
5 Tumor niche and microenvironment Chairpersons Dr. Héctor Peinado and Dr. Joan Seoane Defining the role of tumor secreted exosomes during premetastatic niche formation Dr. Héctor Peinado, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid Nuevos sensores de microambiente como genes supresores Dr. Amancio Carnero, Campus Hospital Universitario Virgen del Rocío (IBIS), Sevilla The TGF-beta pathway as a therapeutic target against cancer Dr. Joan Seoane, Hospital Universitari Vall d Hebrón (VHIO), Barcelona ASPIC Lecture Chairperson Dra. Leonor David The biology and functional contribution of exosomes in cancer progression and metastasis Dr. Sonia Melo, MD Anderson Cancer Center, USA and IPATIMUB-Univ. of Porto, Portugal SATELLITE SYMPOSIUM Nuclear receptors, transcription and cancer Chairpersons Dr. Alberto Muñoz and Dr. Ana Osorio Targeting nuclear receptors: why we need new combinatorial therapies for breast cancer Dr. María del Mar Vivanco, CIC biogune, Vizcaya Role of the transcriptional repressor HDAC7 in leukemia and lymphoma Dr. Maribel Parra, Instituto de Investigación Biomédica de Bellvitge (IDIBELL), Barcelona Vitamin D, VDR and colon cancer Dr. Alberto Muñoz, Instituto de Investigaciones Biomédicas, CSIC-UAM, Madrid
6 Closing session Chairpersons Dr. Pedro A. Lazo and Dr. Carlos Camps Awards ASEICA AND EACR prizes to best communications 1 st ASEICA Young Investigator Award 1 st ASEICA Cancer Research Award Closing lectures Connecting intestinal stem cells to colorectal cancer Dr. Eduard Batlle, Institut de Recerca Biomèdica (IRB), Barcelona 15 th ASEICA Spanish Society for Cancer Research EACR Lecture Targeting K-Ras signaling in cancer Dr. Mariano Barbacid, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid ASEICA general assembly
7 Organized by With the special support of Technical Secretariat TACTICS MD París 162, Pral 1, Barcelona - T info@tacticsmd.net
15 th ASEICA INTERNATIONAL CONGRESS
Sevilla 21-23 october 2015 15 th ASEICA Spanish Society for Cancer Research Hotel NH Collection Sevilla. Avda Diego Martinez Barrio, 8, 41013 Sevilla Organizing Committee President Dr. Pedro Lazo-Zbikowski
Education Session 1. Education Session 2. Inaugural Session
WEDNESDAY 4 NOVEMBER 2015 Education Session 1 09:30-10:30 S1a: Cell and viral vector manufacturing and distribution under GMP Chair: Ana Sanchez S1b: Systems biology: computational methods applied to advanced
CNIO Frontiers Meetings Molecular Cancer Therapeutics Madrid, March 8 10, 2010
CNIO Frontiers Meetings Molecular Cancer Therapeutics Madrid, March 8 10, 2010 Organisers S. Gail Eckhardt, University of Colorado Denver, Aurora, USA Roy S. Herbst, The University of Texas MD Anderson
Scientific Programme
Scientific Programme Scientific Committee Hilary Calvert UCL Cancer Institute, London, UK Luca Gianni Ospedale San Raffaele IRCCS, Milan, Italy Ana Maria Gonzalez-Angulo Cristiana Sessa Istituto Oncologico
ORGANIZERS Fundación para la Investigación Médica Aplicada FIMA Clínica Universidad de Navarra CUN
D International Symposium: Immunostimulatory monoclonal antibodies and immunomodulation: harvesting the crop Fundación Ramón Areces GENERAL INFORMATION DATES OCTOBER 18th 20th VENUE University of Navarra.
Scientific Program Call for Abstracts Registration Accommodation
SECOND ANNOUNCEMENT Scientific Program Call for Abstracts Registration Accommodation Deadline for abstract submission: September 20 th, 2011 www.madridbreastcancer2011.com Madrid, November 16-17, 2011
Resolving Cancer Heterogeneity:
INTERNATIONAL SYMPOSIUM ON: Resolving Cancer Heterogeneity: The way to personalised medicine Palazzo della Gran Guardia Verona (Italy), June 30 th July 2 nd, 2016 PROGRAM Organized by: ARC-Net Centre for
A novel molecular mechanism involved in cancer development revealed by targeting MafB to hematopoietic progenitors
A novel molecular mechanism involved in cancer development revealed by targeting MafB to hematopoietic progenitors Carolina Vicente Dueñas Instituto de Biología Molecular y Celular del Cáncer (IBMCC) (CSIC-Universidad
ESO INSIDE TRACK CONFERENCE. 3 rd FAMILIAL CANCER CONFERENCE. 5-6 June 2008 Madrid, Spain MADRID. Chair: J.Benitez, ES - R. Eeles, UK - H.
ESO INSIDE TRACK CONFERENCE MADRID 3 rd FAMILIAL CANCER CONFERENCE 5-6 June 2008 Madrid, Spain Chair: J.Benitez, ES - R. Eeles, UK - H.Vasen, NL ABSTRACT SUBMISSION Poster abstract deadline 1 APRIL 2008.
Regulation of Protein Translation and c-jun expression by Prostate Tumor Overexpressed1 (PTOV1)
Regulation of Protein Translation and c-jun expression by Prostate Tumor Overexpressed1 (PTOV1) Verónica Cánovas, PhD Student Laboratory of Cell Signalling and Cancer Progression, Dra. Rosanna Paciucci
Scientific Committee Hilary Calvert UCL Cancer Institute, London, United Kingdom
Scientific Committee Hilary Calvert UCL Cancer Institute, London, United Kingdom Luca Gianni Fondazione Centro San Raffaele del Monte Tabor, Milan, Italy Ana Maria Gonzalez-Angulo M.D. Anderson Cancer
Promises and challenges of developing new drugs in oncology
3 rd International Michelangelo Conference Promises and challenges of developing new drugs in oncology Chairman: Luca Gianni, Milan I July 2-3, 2015 Venue: Museo della Scienza e della Tecnologia Via San
Promises and challenges of developing new drugs in oncology
3 rd International Michelangelo Conference Promises and challenges of developing new drugs in oncology Chairman: Luca Gianni, Milan I July 2-3, 2015 Venue: Museo della Scienza e della Tecnologia Via San
13 May 14 May. SESSION 2.- Advances in hearing loss research II Chair: Andrew Forge
13 May 14 May 15:00-17:00 Registration 15:45-16:00 Welcome on behalf of the organizers José María Millán. Unit of Genetics La Fé Hospital. CIBERER. Valencia. Spain. 16:00-16:30 Francesc Palau. CIBERER
Towards the utilization of cannabinoids as anti-cancer
Towards the utilization of cannabinoids as anti-cancer agents Guillermo Velasco Sestri Levante September 2015 Anti-cancer activity of cannabinoids Munson et al. (1975) Antineoplastic activity of cannabinoids
Biomedicine The background. The main interest. The tools
1 Biomedicine The background The main interest? Bioinformatics Clinical informatics The tools 2 Outline 3 Outline 4 Working on Network Data Analysis HH RR Infrastructure Training BIOCOMPUTATION & STRUCTURAL
SCIENTIFIC SECRETARY. - Richard Baird, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK
PROGRAM CHAIRMEN - Bruce A. Chabner, Massachusetts General Hospital Cancer Center, Boston, Massachusetts, USA - Hernán Cortés-Funes, Hospital Universitario 12 de Octubre, Instituto de Investigación i+12,
Cancer SBL101. James Gomes School of Biological Sciences Indian Institute of Technology Delhi
Cancer SBL101 James Gomes School of Biological Sciences Indian Institute of Technology Delhi All Figures in this Lecture are taken from 1. Molecular biology of the cell / Bruce Alberts et al., 5th ed.
Evaluation of focal adhesions as new therapeutic targets in acute myeloid leukemia
Evaluation of focal adhesions as new therapeutic targets in acute myeloid leukemia Dr Jordi Sierra Gil IRHSP Institut de Recerca Hospital de la Santa Creu i Sant Pau Dr. Miguel Ángel Sanz Alonso Fundación
ESO INSIDE TRACK CONFERENCE. 4 th FAMILIAL CANCER CONFERENCE. 7-8 June 2010 Madrid, Spain. Chair: J. Benítez, ES - H. Vasen, NL MADRID 07/06/10
ESO INSIDE TRACK CONFERENCE MADRID 07/06/10 4 th FAMILIAL CANCER CONFERENCE 7-8 June 2010 Madrid, Spain Chair: J. Benítez, ES - H. Vasen, NL APPLICATION AND ABSTRACT SUBMISSION Poster abstract deadline
Speakers * * ** * * * * * * * * * * * * * * * * ** * * * * * * * ** * * * * ** * * * * * * ** * * * * * * * *
Quasispecies: past, present and future 30 th anniversary VIII Jornada de Virologia SCB November 17-18, 2008 Institut d Estudis Catalans, Barcelona, Spain Speakers Christof Biebricher Albert Bosch Carlos
MADRID 11/06/09 EPIGENETICS AND NEW THERAPIES IN CANCER. 11-12 June 2009 Madrid, Spain ESO INSIDE TRACK CONFERENCE
ESO INSIDE TRACK CONFERENCE MADRID 11/06/09 EPIGENETICS AND NEW THERAPIES IN CANCER 11-12 June 2009 Madrid, Spain Chair: M. Esteller, ES Coordinators: S. Marsoni, IT - M.A. Piris, ES APPLICATION AND ABSTRACT
ESO INSIDE TRACK CONFERENCE. 4 th FAMILIAL CANCER CONFERENCE. 7-8 June 2010 Madrid, Spain. Chair: J. Benítez, ES - H. Vasen, NL MADRID 07/06/10
ESO INSIDE TRACK CONFERENCE MADRID 07/06/10 4 th FAMILIAL CANCER CONFERENCE 7-8 June 2010 Madrid, Spain Chair: J. Benítez, ES - H. Vasen, NL APPLICATION AND ABSTRACT SUBMISSION Poster abstract deadline
Programme. Michele Grieco Dipartimento di Scienze Ambientali Seconda Università degli Studi di Napoli Naples, Italy
Programme Invited Speakers: Reuven Agami (The Netherlands), Manuela Baccarini (Austria), Allan Balmain (USA), Daniel Birnbaum (France), Anne-Lise Børresen-Dale (Norway), Carlos Caldas (UK), Silvana Canevari
EACR AACR SIC. from Cancer Biology to the Clinic. Advance Programme & Call for Abstracts ITALY 20-23 JUNE. Anticancer Drug Action and Drug Resistance:
Anticancer Drug Action and Drug Resistance: from Cancer Biology to the Clinic Organised by: Advance Programme & Call for Abstracts -- ORGANIZING COMMITTEE n Richard Marais (UK) - Conference Co-Chair n
INDUSTRY-ACADEMIC-CLINICAL FORUM
INDUSTRY-ACADEMIC-CLINICAL FORUM FUTURE TRENDS IN NANOMEDICINE FOR DIAGNOSTICS AND THERAPY IN ONCOLOGY Parc Científic de Barcelona / Barcelona Science Park 25 th of October of 2012 TABLE OF CONTENTS Agenda
30-31. Advancesincancer immunologyand immunotherapy. announcement. October2015. Royal Olympic Hotel Athens
Advancesincancer immunologyand immunotherapy 30-31 October2015 Royal Olympic Hotel Athens announcement Organizer Hellenic Oncology Research Group (HORG) Symposium chairs N. Kentepozidis, A. Kotsakis, M.
WORKSHOPS CURRE T TRE DS I BIOMEDICI E
WORKSHOPS CURRE T TRE DS I BIOMEDICI E 2013 SEDE A TO IO MACHADO BAEZA, SPAI MEMBRA E TRAFFIC AT THE SY APSE. THE CELL BIOLOGY OF SY APTIC PLASTICITY Baeza, Spain 7 th -9 th October 2013 Organized by:
Future Oncology: Technology, Products, Market and Service Opportunities
Brochure More information from http://www.researchandmarkets.com/reports/296370/ Future Oncology: Technology, Products, Market and Service Opportunities Description: Future Oncology is an analytical newsletter
TARRACO-MALACCA III JOINT WORKSHOP
TARRACO-MALACCA III JOINT WORKSHOP Venue: Hotel Guitart Gold Central Park Resort & Spa, Lloret de Mar Congress language: English/Spanish Organizing Committee: Dr. Joan J. Vendrell (University Hospital
1 page Overview. CONCURRENT 1D, 1E, 1F Biology & Pathogenesis Multi-Modality Immunology 1
1 page Overview 21 Oct Tuesday 1500 on REGISTRATION 1800 Welcome Reception & Cocktails at the Cape Town International Conference Centre (CTICC) 22 Oct Wednesday 0730 REGISTRATION 0830 OPENING 0900 PLENARY
Scientific Program. Advances in the Treatment of Digestive Tumours. Symposium. International. Under the auspices of: Accredited by:
Advances in the Treatment of Digestive Tumours Scientific Program 22 International Symposium Barcelona (Spain) 11th and 12th December 2014 HOTEL BARCELÓ SANTS Under the auspices of: FEDERATION OF SPANISH
Future Directions in Cancer Research What does is mean for medical physicists and AAPM?
Future Directions in Cancer Research What does is mean for medical physicists and AAPM? John D. Hazle, Ph.D., FAAPM, FACR President-elect American Association of Physicists in Medicine Professor and Chairman
1 st ESE Postgraduate Course in Molecular and Cellular Endocrinology
1 st ESE Postgraduate Course in Molecular and Cellular Endocrinology September 5-7, 2006. University of Córdoba Córdoba. Spain. Dear Colleagues, It is a pleasure to welcome you to Córdoba for the celebration
FAMILIAL CANCER ESO, CNIO AND NRCO CONFERENCE ON. 19-20 May 2016 Madrid, Spain. Chairs: R. Eeles, UK W.D. Foulkes, CA M. Robledo, ES H.
INSIDE TRACK CONFERENCE ESO, CNIO AND NRCO CONFERENCE ON FAMILIAL CANCER 19-20 May 2016 Madrid, Spain Chairs: R. Eeles, UK W.D. Foulkes, CA M. Robledo, ES H. Vasen, NL FOREWORD The ESO, CNIO and NRCO Conference
Scientific Committee. Andrés Cervantes (ESMO, GEICO) Antonio González (ESMO, GEICO) Andrés Poveda (ESMO, GEICO) Jan B. Vermorken (ESMO, GEICO)
Under the Auspices of Organized by 10th International Symposium Advanced Ovarian Cancer: Optimal Therapy. Update Valencia, Spain, 6th March 2015 Directors Andrés Poveda Fundación Instituto Valenciano de
Understanding the Molecular and Cellular Biology of Endocrine-Related Cancers. Mont Ste. Odile, Alsace, France 11-14 September 2008
33 rd European Symposium on Hormones and Cell Regulation Understanding the Molecular and Cellular Biology of Endocrine-Related Cancers Mont Ste. Odile, Alsace, France 11-14 September 2008 Invited Speakers:
OPINION ON BLOOD AND TISSUE BANKS OF THE UMBILICAL CORD AND PLACENTA
67/CNECV/2012 OPINION ON BLOOD AND TISSUE BANKS OF THE UMBILICAL CORD AND PLACENTA A joint report by the Portuguese National Council of Ethics for the Life Sciences and the Spanish Bioethics Committee
14 th ASEICA INTERNATIONAL CONGRESS
14 th ASEICA INTERNATIONAL CONGRESS Spanish Society for Cancer Research Madrid 23 rd -25 th September 2013 Hospital universitario Ramón y Cajal SaludMadrid Hospital Universitario Ramón y Cajal Comunidad
WORKSHOP ON THE CONSERVATION OF THE SUBTERRANEAN CULTURAL HERITAGE. Seville, Spain. 25-27 March 2014
WORKSHOP ON THE CONSERVATION OF THE SUBTERRANEAN CULTURAL HERITAGE Seville, Spain 25-27 March 2014 ORGANIZED BY TECHNOHERITAGE SPANISH NETWORK OF SCIENCE AND TECHNOLOGY FOR THE CONSERVATION OF CULTURAL
Dialnet. Author Identification. Eduardo Bergasa eduardo.bergasa@unirioja.es
Dialnet Author Identification Eduardo Bergasa eduardo.bergasa@unirioja.es Fundación Dialnet! Public non-profit foundation! Spin-off of University of La Rioja! Constitution: 2009! In charge of Dialnet portal
eso InSIDe TrACK COnferenCe CAnCer COnferenCe 5-6 June 2014 Madrid, Spain Chairs: j. Benítez, es R. eeles, uk H. Vasen, nl
eso InSIDe TrACK COnferenCe 6 TH familial CAnCer COnferenCe 5-6 June 2014 Madrid, Spain Chairs: j. Benítez, es R. eeles, uk H. Vasen, nl Dear Colleagues, The 6th Familial Cancer Conference hosted once
I N V E S T O R P R E S E N TAT I O N B I O T R I N I T Y L o n d o n A p r i l 2 0 1 6
I N V E S T O R P R E S E N TAT I O N B I O T R I N I T Y L o n d o n A p r i l 2 0 1 6 DISCLAMER This document has been prepared by Oryzon Genomics, S.A. exclusively for use during the presentation. Oryzon
Heterogeneity among early-stage K-Ras driven lung adenocarcinoma predicts tumour aggressiveness and identifies novel therapeutic targets
Heterogeneity among early-stage K-Ras driven lung adenocarcinoma predicts tumour aggressiveness and identifies novel therapeutic targets Canceropole 17.10.14 Introduction: Ras and human cancer Ras Mutations
- PRELIMINARY PROGRAM -
- PRELIMINARY PROGRAM - MADRID. SPAIN, JUNE 9 th - 10 th 2011 SALÓN DE ACTOS CONSEJO SUPERIOR DE INVESTIGACIONES CIENTÍFICAS CSIC C/ SERRANO 117, 28006 MADRID THURSDAY, 9 th June 2011 7.45 8.30 REGISTRATION
MATHEMATICAL ONCOLOGY: NEW CHALLENGES FOR SYSTEMS BIOMEDICINE
International Centre for Scientific Culture E. Majorana" School of Mathematics G. Stampacchia MATHEMATICAL ONCOLOGY: NEW CHALLENGES FOR SYSTEMS BIOMEDICINE September 26-30, 2011 Program of Lectures Monday
Spain: ICT R&D and participation to FP7
Spain: ICT R&D and participation to FP7 Research & Development expenditure in ICT In 2011, public support for ICT R&D (ICT GBAORD) in Spain was 686.7M, roughly 9% of total public funding for R&D, which
How To Treat Mesothelioma With A Tumor Stem Cell Inhibitor
FAK INHIBITOR DEFACTINIB (VS-6063) TARGETS MESOTHELIOMA CANCER STEM CELLS Rationale for maintenance therapy after conventional therapy Jonathan Pachter, Ph.D. Vice President of Research, Verastem, Inc.
The EU s Seventh Framework Programme for R&D: Making the most of the 2013 Calls
The EU s Seventh Framework Programme for R&D: Making the most of the 2013 Calls DATE: 12 September 2012 TIMETABLE: From 9h30 to 17h15 VENUE: Headquarters of the Spanish National Research Council (CSIC)
International Symposium on Stem Cell Research November 12 to 14, 2009 Buenos Aires, Argentina
International Symposium on Stem Cell Research November 12 to 14, 2009 Buenos Aires, Argentina Organizer: Ministry of Science, Technology and Productive Innovation of Argentina Sponsor: International Society
Targeting Specific Cell Signaling Pathways for the Treatment of Malignant Peritoneal Mesothelioma
The Use of Kinase Inhibitors: Translational Lab Results Targeting Specific Cell Signaling Pathways for the Treatment of Malignant Peritoneal Mesothelioma Sheelu Varghese, Ph.D. H. Richard Alexander, M.D.
INTERNATIONAL COURSE:
INTERNATIONAL COURSE: Novel mechanisms of signal transduction involved in cancer chemoresistance - Focus on IGF signaling integration and cross-talk. University Campus S Venuta - Catanzaro, Italy Lecture
treatments) worked by killing cancerous cells using chemo or radiotherapy. While these techniques can
Shristi Pandey Genomics and Medicine Winter 2011 Prof. Doug Brutlag Chronic Myeloid Leukemia: A look into how genomics is changing the way we treat Cancer. Until the late 1990s, nearly all treatment methods
30 th Annual meeting of the Ohio Physiological Society held at the University of Toledo College of Medicine and Life Sciences
30 th Annual meeting of the Ohio Physiological Society held at the University of Toledo College of Medicine and Life Sciences Dr. Lance Stechschulte Postdoctoral Fellow Department of Physiology and Pharmacology
Scientific Programme
Scientific Programme Scientific Committee Hilary Calvert UCL Cancer Institute, London, UK Luca Gianni Ospedale San Raffaele IRCCS, Milan, Italy Ana Maria Gonzalez-Angulo The University of Texas, MD Anderson
Sarcoma Research Group Group leader: Òscar Martínez Tirado
Sarcoma Research Group Group leader: Òscar Martínez Tirado IDIBELL since 2007 Miguel Servet program (Fondo de Investigaciones Sanitarias) 2009 Sarcoma Research Group (SGR682) Group leader: Òscar Martínez
What is Cancer? Cancer is a genetic disease: Cancer typically involves a change in gene expression/function:
Cancer is a genetic disease: Inherited cancer Sporadic cancer What is Cancer? Cancer typically involves a change in gene expression/function: Qualitative change Quantitative change Any cancer causing genetic
What is New in Oncology. Michael J Messino, MD Cancer Care of WNC An affiliate of Mission hospitals
What is New in Oncology Michael J Messino, MD Cancer Care of WNC An affiliate of Mission hospitals Personalized Medicine Personalized Genomics Genomic Medicine Precision Medicine Definition Application
Cancer treatment and diabetes
Cancer treatment and diabetes Dr Daniel Morganstein Consultant Endocrinologist, 1 2 Diabetes and cancer Cancer and its treatment also poses challenges to managing diabetes Surgery Altered appetite Cachexia
How To Learn More About Melanoma
PROGRAMMA SCIENTIFICO MELANOMA BRIDGE 2012, DECEMBER 2 ND -4 TH 2012 Presidents: Paolo A. Ascierto, Francesco M. Marincola and Nicola Mozzillo Scientific Board Paolo A. Ascierto Gennaro Ciliberto Bernard
LESSON 3.5 WORKBOOK. How do cancer cells evolve? Workbook Lesson 3.5
LESSON 3.5 WORKBOOK How do cancer cells evolve? In this unit we have learned how normal cells can be transformed so that they stop behaving as part of a tissue community and become unresponsive to regulation.
Genomic Analysis of Mature B-cell Malignancies
Genomic Analysis of Mature B-cell Malignancies Update and Lessons Learned Omar Abdel-Wahab, MD Memorial Sloan Kettering Cancer Center Human Oncology and Pathogenesis Program and Leukemia Service Disclaimer:
WORKSHOP IN LUNG CANCER CLINICAL RESEARCH Improving opportunities in the LATAM region
WORKSHOP IN LUNG CANCER CLINICAL RESEARCH Improving opportunities in the LATAM region April 2016 27-30 Santiago - Chile Hotel Diego de Almagro San Pío X 2530, Providencia, Santiago. INFORMATION www.lungcancerworkshop.cl
LEUKEMIA LYMPHOMA MYELOMA Advances in Clinical Trials
LEUKEMIA LYMPHOMA MYELOMA Advances in Clinical Trials OUR FOCUS ABOUT emerging treatments Presentation for: Judith E. Karp, MD Advancements for Acute Myelogenous Leukemia Supported by an unrestricted educational
Updated: 18/2/2015 PERSONAL PROFILE
Carlos J. Perez del Pulgar Escuela de Ingenierías C/Ortiz Ramos s/n 29071 Málaga (Spain) Landline: +34 951952324 Email: carlosperez@uma.es www.isa.uma.es/cperez Updated: 18/2/2015 PERSONAL PROFILE Since
American Cancer Society Extramural Grants
Page: 1 Clinical Research Professorship (CRP) CRP-14-114-06 Eng, Charis, MD, PhD Cleveland Clinic Foundation Genomic Medicine Institute PTENopathies and Cancer Phenomics 07/01/2014 06/30/2019 $400,000
Academic Research in Europe Dra. Eva Carrasco
Academic Research in Europe Dra. Eva Carrasco Scientific Director Spanish Breast Cancer Research Group Type of clinical trials Type 1: Designed and sponsored by the Pharmaceutical Industry, proposed to
Curriculum Vitae Harvard Medical School/ Harvard School of Dental Medicine
Curriculum Vitae Harvard Medical School/ Harvard School of Dental Medicine Date Prepared: November 16, 2009 Name: Zafira Castaño Corsino, Ph.D. Work Phone: (34) 659306730 Work Email: Place of Birth: zcastan@hotmail.com
Access to hormone receptor testing and other basic diagnostic pathology services in Colombia
Access to hormone receptor testing and other basic diagnostic pathology services in Colombia Dr Fernando Perry Clínica de seno y tejidos blandos Instituto Nacional de Cancerología de Colombia Breast cancer
Targeted Therapy What the Surgeon Needs to Know
Targeted Therapy What the Surgeon Needs to Know AATS Focus in Thoracic Surgery 2014 David R. Jones, M.D. Professor & Chief, Thoracic Surgery Memorial Sloan Kettering Cancer Center I have no disclosures
Sommaire projets sélectionnés mesure 29: Soutien à la recherche translationnelle
Sommaire projets sélectionnés mesure 29: Soutien à la recherche translationnelle TITLE PROJET NOM HOPITAL Assessment of tumor angiogenesis using PET/CT with 18 F-Galacto- RGD. (PNC_29_001) Division of
DRAFT PROGRAMME Transbio Valencia event
DRAFT PROGRAMME Transbio Valencia event February 27th and 28th Field Study Best practices for company creation and development Workshop Housing & access to technologies for biotech companies Calendar February
Liver. Meeting. International. on living donor. transplantation. After Fifteen Years (2000-2015)
Preliminary Program International Meeting ORGANIZED BY Hospital Clínic Hospital Universitari Vall d Hebron Liver Transplantation Units faculty Scientific committee Juan Carlos García-Valdecasas Ramón Charco
Cellular, Molecular, and Biochemical Targets in Breast Cancer
Cellular, Molecular, and Biochemical Targets in Breast Cancer Kristy Kummerow Ingrid Meszoely December 12, 2012 VUMC Resident Bonus Conference One size fits all surgical treatment of breast cancer Wilhelm
How To Understand And Understand The Business Of Advanced Marker Discovery
Advanced Marker Discovery S. L. Executive Summary CONFIDENTIAL The document is an introduction to Advanced Marker Discovery, S.L., ( Amadix or the Company ) and is not an offer to sell, or a solicitation
Nano and food in Spain: Prof. Josep Samitier Spanish Nanomedicine Platform
Nano and food in Spain: Prof. Josep Samitier Spanish Nanomedicine Platform Institute for Bioengineering of Catalonia (IBEC) University of Barcelona; Ciber-BBN; Barcelona, 5-June - 2012 EFSA SCIENTIFIC
AUDITORIUM ALFREDO KRAUS
AUDITORIUM ALFREDO KRAUS LAS PALMAS DE GRAN CANARIA JUNE 27-29th 2014 Organized by: Activity accredited by the Catalan Council for Continuing Medical Education 09/10879-MD 1,6 Credits groupgem.org Organizing
BIOGRAPHY OF THE MEMBERS OF THE AIREF ADVISORY BOARD
BIOGRAPHY OF THE MEMBERS OF THE AIREF ADVISORY BOARD RAFAEL ÁLVAREZ BLANCO Rafael Álvarez Blanco was director of the department of statistics and central balance sheets at the Bank of Spain for 24 years
Diagnostic and Therapeutic Colonoscopy for Colorectal Neoplasia in the 21st Century: Expanding the Scope to IBD
Marbella (Spain), January 17th & 18th, 2013 Diagnostic and Therapeutic Colonoscopy for Colorectal Neoplasia in the 21st Century: Thursday, January 17th 2013 8:45-9:00 Welcome to the Hands-on Course Andres
UCM Quick Facts 2014-2015
UCM Quick Facts 2014-2015 Departamento de Estudios e Imagen Corporativa STUDENTS ACADEMIC YEAR 2013-2014 Total Official Enrolment 81,218 Enrolment in UCM Centers 72,454 Bachelor s s 49,383 Year s and Higher
LIQUID BIOPSY: TRACKING CANCER
SYMPOSIUM LIQUID BIOPSY: TRACKING CANCER 29-30 April 2016 first announcement Pierre-Auguste Renoir Chemin montant dans les hautes herbes Organizing Secretariat CONGRESS LINE Via Cremona, 19-00161 Rome
Data from an interim analysis from the pivotal Phase 3 trial of YONDELIS in soft tissue sarcoma, SAR-3007, will be presented in an oral presentation
PharmaMar announces new advances in oncology at ASCO 2015 for its compounds YONDELIS and PM1183 in small cell lung cancer, soft tissue sarcoma, and mesothelioma Compelling clinical activity of PM1183 in
The Diagnosis of Cancer in the Pathology Laboratory
The Diagnosis of Cancer in the Pathology Laboratory Dr Edward Sheffield Christmas Select 74 Meeting, Queen s Hotel Cheltenham, 3 rd December 2014 Agenda Overview of the pathology of cancer How specimens
The Biological Basis of Cancer. Annie Young, Professor of Nursing, University of Warwick, University Hospitals Coventry and Warwickshire
The Biological Basis of Cancer Annie Young, Professor of Nursing, University of Warwick, University Hospitals Coventry and Warwickshire Aim of Presentation By the end of this presentation you will: Be
Department of BioScience Technology Chung Yuan Christian University 2015/08/13
Department of BioScience Technology Chung Yuan Christian University 2015/08/13 Cancer Cells Cancer, the 1st leading cause of death, is an example of a disease that arises from abnormalities in cell function
European Course Minimally Invasive Spinal Surgery Hands-on Course EUCMISS MADRID 2013 Madrid, 14-15 June, 2013
VENUE Anatomy Laboratory Universidad San Pablo CEU Campus Montepríncipe Madrid European Course Minimally Invasive Spinal Surgery ENDOSCOPIC DISCECTOMY XLIF TLIF TUBULAR APPROACHES PERCUT. PEDICULAR SCREWS
Targeted Therapies in Lung Cancer
Targeted Therapies in Lung Cancer I Edited by: Simona Carnio Thoracic Oncology Division - St Luigi Hospital Orbassano (TO) - Italy Silvia Novello Department of Oncology - University of Torino - Italy Why
Wednesday, January 24, 2007
Wednesday, January 24, 2007 h. 11.00/12.30 Registration and poster positioning (just for Poster Session I) h. 13.00/14.30 Welcome lunch h. 14.30/14.40 Opening remarks Enrico Garattini, Istituto Ricerche
2011 IRCC International Conference Molecular Clinical Oncology May 26th-28th, 2011, Torino Italy
Updated May 23rd, 2011 2011 IRCC International Conference Molecular Clinical Oncology May 26th-28th, 2011, Torino Italy Thursday May 26 th, 2011 (afternoon) Venue: Aula Magna Rettorato 14.00 16.00 Registration
Physical Activity and Health Education in European Schools
Physical Activity and Health Education in European Schools 1 INTRODUCCTION Health(a)ware is an open and dynamic symposium which focuses on Physical Activity as a privileged subject to approach health in
Updated: 6/10/2015 PERSONAL PROFILE
Carlos J. Pérez del Pulgar Escuela de Ingenierías C/Ortiz Ramos s/n 29071 Málaga (Spain) Landline: +34 951952324 Email: carlosperez@uma.es www.isa.uma.es/cperez Updated: 6/10/2015 PERSONAL PROFILE Since
Diagnostic and Therapeutic Colonoscopy for Colorectal Neoplasia in the 21st Century: Focus on IBD
Marbella (Spain), January 29th & 30th, 2015 Diagnostic and Therapeutic Colonoscopy for Colorectal Neoplasia in the 21st Century: Preliminary Program Thursday, January 29th 2015 15:45-16:00 Welcome to the
Modern Trends in Infectious Diseases and Immunology: Training course for Paediatric Infectious Diseases Trainees Sevilla-Madrid-Barcelona 2013/2014
Modern Trends in Infectious Diseases and Immunology: Training course for Paediatric Infectious Diseases Trainees Sevilla-Madrid-Barcelona 2013/2014 Course Description Paediatric Infectious Diseases (PID)
ELCC 2015 Industry Satellite Symposium The Treatment Roadmap for Squamous NSCLC. Thursday 16th April 2015 13:10 14:20 Room C
ELCC 2015 Industry Satellite Symposium The Treatment Roadmap for Squamous NSCLC Thursday 16th April 2015 13:10 14:20 Room C 1 Contents Programme.... 2 Welcome message.... 3 Faculty biographies.... 4 Symposium
CancerStemCell Markers in Lung Cancers: Proofsof. Reservations. Lourdes Cortes-Dericks, PhD University of Hamburg Hamburg, Germany
CancerStemCell Markers in Lung Cancers: Proofsof ConceptsandSome Reservations Lourdes Cortes-Dericks, PhD University of Hamburg Hamburg, Germany Lung cancer: highest death rate and poorest patient survival
Cellular Cell Theraputic Results in Spain
CELL THERAPY FROM THE BENCH TO THE BEDSIDE AND RETURN Directors: JOSE MARIA MORALEDA JIMENEZ SALVADOR MARTINEZ PEREZ DAMIAN GARCIA OLMO ROBERT SACKSTEIN Los Alcázares (Murcia) 15-19 de Julio 2013 Place:
Signaling monitoring and flow cytometry
Signaling monitoring and flow cytometry Coultry Club, FIAP Paris April 8, 2014 Dr Jacques Nunès Lymphocyte Activation Group 1 PLAN I Signalisation intracellulaire & «signal monitoring» II Méthodologie
29th- 30th October 2015 Hospital Universitario Virgen del Rocío
29th- 30th October 2015 Hospital Universitario Virgen del Rocío Welcoming The isurgitec conference was initiated in 2008 at Cursos de Verano de la Universidad Complutense de Madrid, El Escorial when four
Wednesday, February 24 th, 2016
List of Faculty: Nadeem R. Abu-Rustum, Memorial Sloan Kettering Cancer Center. New York, USA Giovanni Aletti, Istituto Europeo di Oncologia. Milan, Italy Natalia Carballo, David Cibula, General University
How To Make Cancer A Clinical Sequencing
10 this time, it s Personal In what is an exciting era in the evolution of oncology treatment, this special feature by Deborah J. Ausman explores how Next-Generation Sequencing and Convergent Informatics